Clinical trials
Completed Phase 2 Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 7 |
| 2007 | 6 |
| 2008 | 9 |
| 2010 | 2 |
| 2011 | 12 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esperion Therapeutics, Inc. | 9 |
| Amgen | 5 |
| Kastle Therapeutics, LLC | 5 |
| NeuroBo Pharmaceuticals Inc. | 5 |
| Sanofi | 5 |
| Micropharma Limited | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| NewAmsterdam Pharma | 4 |
| Pfizer | 4 |
| Regeneron Pharmaceuticals | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 107 |
| Dyslipidemias | 20 |
| Hyperlipidemias | 16 |
| Cardiovascular Diseases | 9 |
| Atherosclerosis | 6 |
| Lipid Metabolism Disorders | 6 |
| Hypertension | 5 |
| Hypertriglyceridemia | 5 |
| Metabolic Diseases | 5 |
| Hyperlipoproteinemia Type II | 4 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.